Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe history shows a new Revision: v3.3.2 added and Revision: v3.2.0 removed, a minor administrative site update that does not affect study details.SummaryDifference0.0%

- Check28 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedThe updates appear to be a minor UI refresh of the Record History page and version list, with no changes to trial details, statuses, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check71 days agoChange Detected- Added a prominent operating-status notice and guidance related to government funding and NIH Clinical Center. - Updated version to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference8%

- Check78 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

- Check92 days agoChange DetectedUpdated to version v3.0.2 and removed the 'Back to Top' link. No substantive changes to core content, pricing, stock, or time slots.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.